You have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2): A rare genetic condition
Briefly, cells were collected, added with the CEB-A solution, mixed and vortexed, and then added with the CEB-B solution, mixed and vortexed again, followed by centrifugation
This absence suggests that regulatory authorities have not identified major safety signals requiring specific warnings, though it does not constitute evidence of safety or efficacy for combined use
It is about having the right plan, the right dose, and the right support as your body responds
We are excited to start this journey with you
In addition to the foregoing IND requirements, an IRB representing each institution participating in the clinical trial must review and approve the plan for any clinical trial before it commences at that institution, and the IRB must conduct continuing review of the study at least annually